Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 2
1952 2
1953 4
1954 5
1955 5
1956 7
1957 13
1958 2
1959 1
1960 2
1961 8
1962 1
1964 1
1965 1
1967 3
1969 1
1970 2
1973 5
1975 3
1977 1
1978 1
1979 4
1980 1
1981 3
1982 2
1984 1
1985 1
1986 1
1987 6
1988 4
1989 2
1990 6
1991 4
1992 4
1993 7
1994 9
1995 8
1996 4
1997 5
1998 3
1999 6
2000 6
2001 11
2002 5
2003 10
2004 4
2005 6
2006 3
2007 5
2008 6
2009 4
2010 11
2011 8
2012 10
2013 9
2014 13
2015 11
2016 13
2017 7
2018 9
2019 9
2020 5
2021 7
2022 14
2023 9
2024 8
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

338 results

Results by year

Filters applied: . Clear all
Page 1
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.
Supiot S, Vaugier L, Pasquier D, Buthaud X, Magné N, Peiffert D, Sargos P, Crehange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Denis F, Lagrange JL, Morvan C, Campion L, Blanc-Lapierre A. Supiot S, et al. Among authors: lagrange jl. Eur Urol. 2021 Oct;80(4):405-414. doi: 10.1016/j.eururo.2021.06.010. Epub 2021 Jul 8. Eur Urol. 2021. PMID: 34247896 Clinical Trial.
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Carrie C, Magné N, Burban-Provost P, Sargos P, Latorzeff I, Lagrange JL, Supiot S, Belkacemi Y, Peiffert D, Allouache N, Dubray BM, Servagi-Vernat S, Suchaud JP, Crehange G, Guerif S, Brihoum M, Barbier N, Graff-Cailleaud P, Ruffion A, Dussart S, Ferlay C, Chabaud S. Carrie C, et al. Among authors: lagrange jl. Lancet Oncol. 2019 Dec;20(12):1740-1749. doi: 10.1016/S1470-2045(19)30486-3. Epub 2019 Oct 16. Lancet Oncol. 2019. PMID: 31629656 Clinical Trial.
[Image-guided radiotherapy].
de Crevoisier R, Isambert A, Lisbona A, Bodez V, Marguet M, Lafay F, Remonnay R, Lagrange JL. de Crevoisier R, et al. Among authors: lagrange jl. Cancer Radiother. 2007 Nov;11(6-7):296-304. doi: 10.1016/j.canrad.2007.08.002. Epub 2007 Sep 21. Cancer Radiother. 2007. PMID: 17889585 Review. French.
Thromboinflammation and Vascular Dysfunction.
Karbach S, Lagrange J, Wenzel P. Karbach S, et al. Among authors: lagrange j. Hamostaseologie. 2019 Jun;39(2):180-187. doi: 10.1055/s-0038-1676130. Epub 2018 Dec 4. Hamostaseologie. 2019. PMID: 30513535 Review.
Radiotherapy of bone metastases.
Thureau S, Supiot S, Jouglar E, Rogé M, Lebret L, Hadj Henni A, Beldjoudi G, Lagrange JL, Faivre JC. Thureau S, et al. Among authors: lagrange jl. Cancer Radiother. 2022 Feb-Apr;26(1-2):368-376. doi: 10.1016/j.canrad.2021.11.021. Epub 2021 Dec 23. Cancer Radiother. 2022. PMID: 34955420
[Informed consent in radiotherapy care].
Sire C, Ducteil A, Lagrange JL, Maingon P, Lorchel F, Latorzeff I, Hennequin C, Giraud P, Leroy T, Vendrely V, Hannoun-Lévi JM, Chargari C, Pourel N, Elhouat Y, Mazeron JJ, Marchesi V, Huguet F, Monpetit É, Azria D. Sire C, et al. Among authors: lagrange jl. Cancer Radiother. 2024 Jun;28(3):290-292. doi: 10.1016/j.canrad.2024.04.001. Epub 2024 Jun 11. Cancer Radiother. 2024. PMID: 38866651 French.
[Health democracy: Patient partnership].
Haaser T, Constantinidès Y, Dejean C, Escande A, Le Tallec P, Lorchel F, Marty S, Thureau S, Huguet F, Lagrange JL; pour la Commission éthique de la SFRO. Haaser T, et al. Among authors: lagrange jl. Cancer Radiother. 2020 Oct;24(6-7):736-743. doi: 10.1016/j.canrad.2020.06.021. Epub 2020 Aug 27. Cancer Radiother. 2020. PMID: 32861610 French.
[Postoperative radiotherapy of prostate cancer].
Guérif S, Latorzeff I, Lagrange JL, Hennequin C, Supiot S, Garcia A, François P, Soulié M, Richaud P, Salomon L. Guérif S, et al. Among authors: lagrange jl. Cancer Radiother. 2014 Oct;18(5-6):517-23. doi: 10.1016/j.canrad.2014.07.149. Epub 2014 Sep 5. Cancer Radiother. 2014. PMID: 25195116 Review. French.
Myeloid cell-derived interleukin-6 induces vascular dysfunction and vascular and systemic inflammation.
Knopp T, Jung R, Wild J, Bochenek ML, Efentakis P, Lehmann A, Bieler T, Garlapati V, Richter C, Molitor M, Perius K, Finger S, Lagrange J, Ghasemi I, Zifkos K, Kommoss KS, Masri J, Reißig S, Randriamboavonjy V, Wunderlich T, Hövelmeyer N, Weber ANR, Mufazalov IA, Bosmann M, Bechmann I, Fleming I, Oelze M, Daiber A, Münzel T, Schäfer K, Wenzel P, Waisman A, Karbach S. Knopp T, et al. Among authors: lagrange j. Eur Heart J Open. 2024 Jun 12;4(4):oeae046. doi: 10.1093/ehjopen/oeae046. eCollection 2024 Jul. Eur Heart J Open. 2024. PMID: 39015379 Free PMC article.
338 results